An artificial intelligence-powered method for detecting tumor DNA in blood has the potential to improve cancer care with the very early detection of recurrence and close monitoring of tumor response during therapy.
The FDA has approved tirzepatide – which will be sold under the brand name Zepbound – to treat overweight and obesity. It’s the latest entrant into a field of powerful new drugs that includes Ozempic and Wegovy.
The exhibition "Seeds of Survival and Celebration: Plants and the Black Experience" returned for a second season with an expanded plant collection, which honors the lasting influence of the formerly enslaved and their descendants on American culture.
While a strain of highly pathogenic avian influenza virus has been detected in dairy cattle in nine states – not including New York state – the commercial milk supply continues to be safe, according to a panel of experts.
Vaccinating mothers against RSV during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
Jeannine Gerhardt, an assistant professor of stem cell biology in obstetrics and gynecology and in reproductive medicine at Weill Cornell Medicine, has received a five-year, $2.1 million grant for the study of repetitive DNA and RNA sequences and the mechanisms by which they cause cell dysfunction and diseases.
Cornell researchers have developed a bioelectric device that can detect and classify new variants of coronavirus, and potentially other viruses, such as measles and influenza, to identify those that are most harmful.
A new study has identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small-cell lung cancer treated with a combination of immunotherapy and low-dose radiation.
Eating flours, burgers and fitness bars made from crickets, mealworms or black soldier fly larvae could help feed a growing global population sustainably, but it might hit resistance from those who follow halal or kosher regulations.
Feuerstein has founded several digital health companies and is the executive director and founder of Yale School of Medicine’s Center for Digital Health and Innovation.
